TRiCares SAS: TRiCares Successfully Closes Series C Financing, Raising €51m to Fund Further Development and Clinical Trials of Minimally Invasive Treatment for Tricuspid Regurgitation

TRiCares Successfully Closes Series C Financing, Raising €51m to Fund Further Development and Clinical Trials of Minimally Invasive Treatment for Tricuspid Regurgitation Paris, France

Related Keywords

Wellington ,New Zealand General ,New Zealand ,Paris ,France General ,France ,Germany ,United States ,Munich ,Bayern ,Belgium ,Canada ,Frederik Groenewegen ,Helmutj Straubinger ,Kostenloser Wertpapierhandel ,Bayern Kapital ,Matthew Cole ,Fund Further Development ,Consilium Strategic Communications ,Caressuccessfully Closes Seriesc Financing ,Clinical Trials ,Minimally Invasive Treatment ,Andera Partners ,Biomed Partners ,Mutuel Innovation ,Chief Executive Officer ,Georg Ried ,Managing Director ,General Partner ,Wellington Partners ,Tricuspid Regurgitation ,Chief Executive ,Tricares ,Uccessfully ,Loses ,Series ,Financing ,Raising ,Fund ,Urther ,Development ,Linical ,Trials ,Minimally ,Nvasive ,Treatment ,Ricuspid ,Regurgitation ,